AstraZeneca Pharmaceuticals LP
Verified Pharmaceutical Manufacturer & Oncology Drug Supplier
AstraZeneca Pharmaceuticals LP
Verified PartnerRegistered pharmaceutical manufacturer and healthcare technology supplier listed on the ONC-ORG national directory.
Company Profile & Registration
Legal Organization NameAstraZeneca Pharmaceuticals LP
Manufacturer Identification CodeRegistered
Authorized RepresentativeCorporate Representative
Compliance & StatusActive / Listed
Oncology Drugs & Clinical Formulations
Featured Drug Formulation
View Complete Drug Profile Tagrisso
Generic: osimertinib
Class: EGFR Tyrosine Kinase Inhibitor
Indications: Adjuvant therapy after tumor resection in patients with NSCLC whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations; first-line treatment for metastatic EGFR-mutated NSCLC; and EGFR T790M mutation-positive metastatic NSCLC.
Direct Communication & Assistance
Send an Inquiry to AstraZeneca Pharmaceuticals LP
Our oncology navigation desk will route your inquiry regarding medicine access, clinical partnerships, or product availability to the appropriate representative.